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Abstract
Apathy is prevalent in schizophrenia, but its etiology has received little investigation. The ventral 
striatum (VS), a key brain region involved in motivated behavior, has been implicated in studies of 
apathy. We therefore evaluated whether apathy is associated with volume of the VS on MRI in 23 
patients with schizophrenia using voxel-based morphometry. Results indicated that greater self-
reported apathy severity was associated with smaller volume of the right VS even when 
controlling for age, gender, depression, and total gray matter volume. The finding suggests that 
apathy is related to abnormality of brain circuitry subserving motivated behavior in patients with 
schizophrenia.
Apathy may be described as a syndrome characterized by decreased interest or initiative, 
poor persistence in activities, restricted engagement in social interactions, and/or emotional 
indifference.1 Such motivational deficits are common in schizophrenia and have been 
associated with poor compliance with or inability to benefit from treatment,2 functional 
outcomes,3,4 and quality of life.5
A growing neuroimaging literature in neurological populations supports an association 
between apathy and integrity of frontal-subcortical circuitry.6–8 In patients with 
schizophrenia, apathy has been reported to be associated with lower resting cerebral blood 
flow in the frontal lobe,9 smaller volume of the frontal lobes bilaterally,10 as well as 
abnormalities of the cortical thickness and white matter connections of the left orbitofrontal 
cortex and left anterior cingulate cortex.11,12 In addition, apathy has been observed to be 
related to greater impairment on neuropsychological measures sensitive to frontal-
subcortical circuitry dysfunction in both first episode13 and chronic10 patients.
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Among subcortical regions, the ventral striatum (VS) has been receiving increasing attention 
as a possible substrate of apathy.14,15 The VS has been reported in human and animal studies 
to play a role in emotion and goal-directed, motivated behavior including the processing of 
reward.16,17 Structural MRI studies have observed that smaller volume of the VS is 
associated with greater apathy in HIV-positive adults,18 patients with frontotemporal 
dementia,19 and in those with Parkinson’s disease.20 A positron emission tomography study 
of depressed patients with Parkinson’s disease found that greater apathy was associated with 
lower dopamine and noradrenergic transporter binding in the VS.21 Furthermore, functional 
MRI (fMRI) studies have observed that greater apathy, but not other negative symptoms, 
was associated with reduced activation of the VS during anticipation of monetary reward in 
patients with schizophrenia.22–24
In the present investigation, we used MRI and voxel-based morphometry (VBM)25 to 
examine the hypothesis that apathy is associated with reduced gray matter volume in the VS 
of patients with schizophrenia. Such a VBM volume-of-interest approach has been 
implemented in previous research on schizophrenia.26 A measure of depression was 
included as a covariate in the analysis given the partial overlap of the symptoms of apathy 
and depression.27
METHODS
Participants
Participants consisted of 23 patients with DSM-IV diagnoses of schizophrenia (N=14) or 
schizoaffective disorder (N=9), recruited from outpatient community clinics through referral 
to the study by a treatment provider. The sample had a mean age of 39.43 years (SD=12.28), 
52% were men, 87% were right handed, and mean parental education was 13.07 years 
(SD=3.79). Diagnosis was established using the Structured Clinical Interview for DSM-IV-
TR.28
Participants were excluded if they had a history of neurological disorder (e.g., epilepsy, 
neurodegenerative disorder), mental retardation, or significant systemic medical illness. In 
addition, patients were excluded if they had a history of substance abuse within the 6 months 
before participation. All patients were receiving stable doses (at least 12 weeks) of 
antipsychotic medication at the time of the study (atypical only, N=20; both atypical and 
typical, N=2; typical only, N=1), with most taking multiple medications. After complete 
description of the study, written informed consent was obtained following a protocol 
approved by the Dartmouth College Committee for the Protection of Human Subjects.
Procedure
We assessed severity of clinical symptoms using the Scale for the Assessment of Positive 
Symptoms (SAPS)29 and Scale for the Assessment of Negative Symptoms (SANS)30 and 
assessed depression using the Beck Depression Inventory–II (BDI-II).31 The Apathy 
Evaluation Scale (AES) was used to assess self-reported apathy.32 The AES is an 18-item 
questionnaire that is rated on a 4-point scale ranging from “not at all” to “a lot,” with scores 
ranging from 0 to 54, where higher scores indicate greater apathy.
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MRI Data Acquisition
Scans were acquired with a GE Signa 1.5-T Horizon LX magnet (General Electric, Fairfield, 
Conn.) with echo speed gradients using a standard RF head coil. A T1-weighted three-
dimensional spoiled gradient echo (SPGR) coronal volume was acquired. Parameters were 
TR=25 ms, TE=3 ms, flip angle=40 degrees, NEX=1, and slice thickness=1.5 mm (no gap), 
yielding 124 contiguous slices with a 24-cm field of view, and a 256×256 matrix with 
0.9375 mm in-plane resolution. A fast spin echo T2-weighted scan was also acquired to 
screen for focal lesions or other incidental findings (TR=3000, TE=96, 3-mm contiguous 
axial slices).
MRI Data Processing
We performed VBM25 using the statistical parametric mapping package (SPM12; Wellcome 
Department of Imaging Neuroscience, London, UK). This involved automated segmentation 
of gray matter, white matter, and CSF in the SPGR data, nonlinear registration of all images 
to the Montreal Neurological Institute (MNI152) template space via a data-derived gray 
matter/white matter–based template of 1.5 mm3 isotropic resolution created using 
Diffeomorphic Anatomical Registration Through Exponentiated Lie Algebra (DARTEL),33 
with modulation to preserve tissue volumes and spatial smoothing (full width at half 
maximum=4 mm).
Several steps to ensure accurate segmentation were completed, including visual inspection 
of raw images, visual inspection of gray matter, white matter, and CSF segmentations, and 
comparison of the gray matter-to-white matter ratio and total brain volume across 
participants. One scan was discarded based on poor raw image quality (leaving N=23 for 
analysis). Smoothed normalized gray matter maps were used for statistical analysis after a 
final visual inspection of segmentation quality.
To examine gray matter volume in the VS, we performed an analysis using a volume of 
interest (VOI) specified by a voxel mask from a publication-based probabilistic atlas.34 The 
probabilistic VOI mask was thresholded at the 0.5 probability level, which had been 
previously used in fMRI studies of the VS in schizophrenia,35 to create a binary mask. 
Figure 1 [A] illustrates the anatomic boundary of the VOI on the MNI152 template brain.
Statistical Analysis
We conducted statistical parametric mapping, restricted to the VOI, on a voxel-by-voxel 
basis using a general linear model and random-effects analysis as implemented in SPM12. 
Multiple regression analysis was used to examine the correlation between apathy score and 
gray matter volume in the VOI controlling for age, gender, BDI-II score, and total gray 
matter volume. A statistical threshold for significance of p<0.01 was implemented without 
correction for multiple comparisons given the focused VOI approach, although the PWE-
corrected p value is also presented for interested readers. Data are presented in MNI152 atlas 
coordinates.
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RESULTS
The sample had a mean AES score of 14.43 (SD=10.11, range=1–48) indicating a relatively 
mild level of apathy. SAPS (mean=7.0, SD=3.5) and SANS (mean=10.6, SD=3.8) scores 
were also generally in the mild range. BDI-II scores were typically in the minimal to mild 
range (mean=13.3, SD=11.6).
VBM indicated that greater apathy was associated with smaller gray matter volume in the 
right VS VOI [Z=3.67; Puncorrected=0.001, k=21; peak (xyz) = 9, 10, −14; cluster-level pFWE 
of 0.051] (Figure 1 [B]). Furthermore, an exploratory whole-brain analysis also produced a 
significant association of apathy and right VS volume (Z=3.60, p=0.001, k=174), albeit only 
when uncorrected for multiple comparisons. No significant correlation was observed 
between apathy and left VS volume. No significant association was observed between VS 
volume and either BDI-II score or chlorpromazine-equivalent medication dosage.
DISCUSSION
The present investigation revealed an association between greater self-reported apathy and 
reduced gray matter volume in the right VS, particularly the nucleus accumbens, in patients 
with schizophrenia. This relationship was observed despite statistically controlling for 
depression, consistent with other work showing that apathy can be dissociated from 
depression.36–38 Our finding is also in line with investigations in other patient populations 
that have implicated abnormality of the VS in apathy.18,20,21 Furthermore, we observed that 
apathy was related specifically to right VS volume. Such an association between apathy and 
the right VS has previously been observed in studies of schizophrenia22 and frontotemporal 
dementia.19 The precise functional significance of this lateralization, however, remains to be 
elucidated.
A number of authors have proposed that the pathophysiology of apathy involves the VS 
given the region’s involvement in motivation and emotion.14,15 fMRI studies have reported 
that patients with schizophrenia show reduced responsiveness to behaviorally salient stimuli 
in brain regions involved in motivation, such as decreased activation of the VS and related 
basal forebrain regions in response to target stimuli during an auditory oddball task,39 and 
reduced activation of the VS, including the right VS, to cues signaling the possibility of 
obtaining a monetary reward.22–24,40 These findings along with that of the present study 
suggest that apathy in schizophrenia may be due in part to deficient processing of stimuli 
signaling the potential for reward, or a more general dysfunction in processing 
motivationally significant stimuli, resulting from structural and functional abnormalities of 
the VS and related circuitry. Involvement of the VS is also consistent with the affective/
motivational subtype of apathy proposed by Levy.14 In that model, it is argued that 
abnormality of basal ganglia subregions such as the VS and the orbital and mesial prefrontal 
cortices leads to difficulty associating affective/emotional signals with ongoing and future 
behaviors, consequently resulting in diminishing motivation.
It is important to note that it is unlikely that VS abnormality fully accounts for apathy in 
schizophrenia. Case studies involving lesions restricted to the VS are rare and have not been 
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associated with the presence of apathy.41 In a similar manner, behavior akin to apathy has 
not been consistently reported following focal lesions to the VS in primates.42–44 Previous 
research has implicated the frontal lobes in apathy in schizophrenia10–12 and in neurological 
disorders.19,45 It is therefore possible that frontal abnormality is playing a role in driving 
dysregulation of the VS in schizophrenia. A recent fMRI study that observed normal VS 
response, but abnormal striatal-cortical connectivity to motivational cues that was related to 
negative symptom severity in patients with schizophrenia, may support that hypothesis.46 A 
more complete understanding of the etiology of apathy in schizophrenia will therefore 
require further investigation of the structural and functional integrity of subregions within 
the frontal-striatal circuitry, as well as functional connectivity of the circuitry.
The results of the present investigation must be interpreted within the context of its 
limitations. The sample size was modest; therefore, the findings require replication in a 
larger sample, which should also evaluate whether they are upheld when considering 
subtypes of the disorder, gender, and handedness. The relationship observed between apathy 
and VS volume was significant using a focused volume-of-interest approach and is 
consistent with previous studies, but it was nonetheless a relatively small effect. This may be 
due in part to the overall mild severity of apathy in the sample. It is possible that we would 
observe an even stronger relationship in patients with schizophrenia having more severe 
levels of apathy. Further study is also needed to determine whether antipsychotic medication 
could have affected the findings, although the latter seems unlikely given that we found no 
association between VS volume and medication dosage, and a previous study found a 
relationship between apathy and functional activation of the VS in patients with 
schizophrenia taking atypical antipsychotics.22 Finally, although we did not have 
information pertaining to duration of illness in our patient sample, it is unlikely that this 
variable can account for our results given that other work has found that duration of illness is 
unrelated to volume of the accumbens in patients with schizophrenia.47
With those caveats, the present findings provide further support for the hypothesis that 
apathy in schizophrenia is associated with abnormality of neural circuitry subserving 
motivated behavior. Such findings could inform the treatment of apathy, as well as raising 
the possibility of using a neuroimaging marker (i.e., abnormal structure and/or function of 
the VS) to identify patients who may be at elevated risk of experiencing apathy and thus 
provide early intervention.
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FIGURE 1. 
[A] Ventral Striatum Volume of Interest on the MNI152 Template Brain. [B] More Severe 
Self-Reported Apathy Associated With Lower Regional Gray Matter Volume in the Right 
Ventral Striatum in Patients With Schizophrenia.a
a
 Controlling for age, gender, Beck Depression Inventory–II score, and total gray matter 
volume.
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